Aditya Birla Sun Life Mutual Fund
When comparing, both lines start at 100. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare TRI) is not available to us as a series.
Up to one year: absolute. Longer: annualised. Category = median of Sectoral/Thematic direct-plan Growth funds; index = NIFTY 500 TRI.
| Period | This fund | Category median | NIFTY 500 TRI | Rank in category |
|---|---|---|---|---|
| 1 month | -3.01% | -5.43% | -6.32% | — |
| 3 months | +2.78% | -2.83% | -5.14% | — |
| 6 months | +18.84% | +8.81% | +5.07% | — |
| 1 year | +17.50% | +1.34% | -3.80% | #23 of 224 Top 11% |
| 3 years | +20.06% | +12.83% | +9.14% | #18 of 137 Top 14% |
| 5 years | +13.98% | +11.70% | +8.89% | #34 of 99 Top 35% |
| 10 years | — | +14.63% | +12.66% | — |
| Since launch of NAV data | +20.91% | — | — | — |
| Window | High | Low |
|---|---|---|
| 1 month | 41.1200 | 39.6200 |
| 3 months | 41.2300 | 38.5500 |
| 6 months | 41.2300 | 33.0500 |
| 1 year | 41.2300 | 32.3600 |
A period is a dash when the fund has not existed that long or its NAV history has a hole at the start date — never a partial figure.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | YTD | |
|---|---|---|---|---|---|---|---|
| This fund | +56.63% | +21.36% | -11.31% | +39.58% | +37.69% | -3.09% | +16.94% |
| Category median | +14.76% | +32.13% | +5.11% | +32.77% | +22.00% | +4.37% | -2.14% |
| NIFTY 500 TRI | +17.89% | +31.60% | +4.25% | +26.91% | +16.24% | +7.76% | -7.72% |
Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare TRI) is not available to us as a series.
Twenty checks of five points each: performance, portfolio, operations, and risk against reward. Only checks we have data for are counted.
Risk-free rate 6.06% (3-year annualised return of the NSE 1-day (overnight) rate index). Benchmark-relative ratios use NIFTY 500 TRI. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare TRI) is not available to us as a series.
| Ratio | This fund | Category median | Against category |
|---|---|---|---|
| Sharpe ratio | 1.09 | 0.42 | Better |
| Sortino ratio | 1.56 | 0.57 | Better |
| Standard deviation | 12.86% | 15.72% | Better |
| Maximum drawdown | -15.93% | -21.28% | Better |
| Beta | 0.58 | 0.93 | — |
| R-squared | 42.0% | 82.5% | — |
| Jensen's alpha | 12.21% | 3.49% | Better |
| Treynor ratio | 24.17 | 6.74 | Better |
| Information ratio | 0.95 | 0.55 | Better |
| Upside capture | 68.1% | 93.7% | Worse |
| Downside capture | 51.3% | 91.0% | Better |
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | Healthcare | 9.57% | — | 78.2 |
| Sun Pharmaceutical Industries Ltd. | Healthcare | 9.19% | — | 146.5 |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 6.85% | — | 74.7 |
| Cipla Ltd. | Healthcare | 5.16% | — | 35.4 |
| Aurobindo Pharma Ltd. | Healthcare | 4.54% | — | 37.4 |
| Ajanta Pharma Ltd. | Healthcare | 4.22% | — | 44.9 |
| Sai Life Sciences Ltd. | Healthcare | 4.20% | — | 90.6 |
| TREPS | — | 3.85% | — | — |
| Mankind Pharma Ltd. | Healthcare | 3.41% | — | 47.4 |
| Lupin Ltd. | Healthcare | 3.10% | — | 13.3 |
| Abbott India Ltd. | Healthcare | 3.03% | — | 35.7 |
| Emcure Pharmaceuticals Ltd. | Healthcare | 2.99% | — | 45.5 |
| Fortis Healthcare Ltd. | Healthcare | 2.79% | — | 257.5 |
| IPCA Laboratories Ltd. | Healthcare | 2.71% | — | 39.3 |
| Gland Pharma Ltd. | Healthcare | 2.63% | — | 34.3 |
| Divi's Laboratories Ltd. | Healthcare | 2.23% | — | 83.9 |
| Corona Remedies Ltd. | Healthcare | 2.17% | — | 64.5 |
| Dr. Lal Path labs Ltd. | Healthcare | 2.10% | — | 38.7 |
| Thyrocare Technologies Ltd. | Healthcare | 1.94% | — | 34.1 |
| Procter & Gamble Health Ltd. | Healthcare | 1.84% | — | 25.9 |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 1.76% | — | 9.0 |
| Alkem Laboratories Ltd. | Healthcare | 1.69% | — | 28.9 |
| Metropolis Healthcare Ltd. | Healthcare | 1.55% | — | 27.5 |
| Shilpa Medicare Ltd. | Healthcare | 1.27% | — | 111.8 |
| Piramal Pharma Ltd. | Healthcare | 1.24% | — | 39.2 |
| Pfizer Ltd. | Healthcare | 1.19% | — | 24.1 |
| Biocon Ltd. | Healthcare | 1.19% | — | 597.3 |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 1.18% | — | 32.9 |
| Anthem Biosciences Ltd. | Healthcare | 1.15% | — | 77.2 |
| Manipal Health Enterprises Ltd | Healthcare | 1.12% | — | — |
| Vijaya Diagnostic Centre Ltd. | Healthcare | 1.08% | — | 76.7 |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 1.04% | — | 154.7 |
| Suraksha Diagnostic Ltd. | Healthcare | 1.03% | — | 50.3 |
| Natco Pharma Ltd. | Healthcare | 0.92% | — | 16.6 |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 0.90% | — | 44.3 |
| Medi Assist Healthcare Services Ltd. | Financial Services | 0.78% | — | 38.8 |
| Vinati Organics Ltd. | Chemicals | 0.77% | — | 24.3 |
| Syngene International Ltd. | Healthcare | 0.69% | — | 64.2 |
| Max Healthcare Institute Ltd. | Healthcare | 0.66% | — | 126.0 |
| Jubilant Pharmova Ltd. | Healthcare | 0.50% | — | 709.5 |
This is a paid feature
Comparing more months of this fund's own portfolio history is available on paid plans.
Sign inExpense ratio by month: Oct 25 1.03% · Nov 25 1.02% · Dec 25 1.02% · Jan 26 1.02% · Feb 26 1.02% · Mar 26 1.02% · Apr 26 1.01% · May 26 0.99% · Jun 26 1.01% · Jul 26 1.01% · Aug 26 1.02% · Sep 26 1.05%
For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
